Folgen
Borwin Bandelow
Borwin Bandelow
Professor for Psychiatry and Psychotherapy, University of Göttingen
Bestätigte E-Mail-Adresse bei gwdg.de
Titel
Zitiert von
Zitiert von
Jahr
Epidemiology of anxiety disorders in the 21st century
B Bandelow, S Michaelis
Dialogues in clinical neuroscience, 2022
14842022
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders …
B Bandelow, J Zohar, E Hollander, S Kasper, HJ Möller, ...
The World Journal of Biological Psychiatry 9 (4), 248-312, 2008
8792008
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
DS Baldwin, IM Anderson, DJ Nutt, B Bandelow, A Bond, JRT Davidson, ...
Journal of Psychopharmacology 19 (6), 567-596, 2005
7332005
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the …
DS Baldwin, IM Anderson, DJ Nutt, C Allgulander, B Bandelow, ...
Journal of Psychopharmacology 28 (5), 403-439, 2014
5972014
Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder
A Broocks, B Bandelow, G Pekrun, A George, T Meyer, U Bartmann, ...
American Journal of Psychiatry 155 (5), 603-609, 1998
5291998
Treatment of anxiety disorders
B Bandelow, S Michaelis, D Wedekind
Dialogues in clinical neuroscience, 2022
5142022
Efficacy of treatments for anxiety disorders: a meta-analysis
B Bandelow, M Reitt, C Röver, S Michaelis, Y Görlich, D Wedekind
International clinical psychopharmacology 30 (4), 183-192, 2015
4782015
Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controls
B Bandelow, J Krause, D Wedekind, A Broocks, G Hajak, E Rüther
Psychiatry research 134 (2), 169-179, 2005
4142005
Assessing the efficacy of treatments for panic disorder and agoraphobia: II. The Panic and Agoraphobia Scale.
B Bandelow
International clinical psychopharmacology, 1995
4111995
Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care
B Bandelow, L Sher, R Bunevicius, E Hollander, S Kasper, J Zohar, ...
International journal of psychiatry in clinical practice 16 (2), 77-84, 2012
4052012
WFSBP Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders: World Federation of Societies of Biological Psychiatry (WFSBP …
B Bandelow, J Zohar, E Hollander, S Kasper, HJ Möller
World J Biol Psychiatry 9 (4), 248-312, 2008
2502008
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition
B Bandelow, D Baldwin, M Abelli, B Bolea-Alamanac, M Bourin, ...
The World Journal of Biological Psychiatry 18 (3), 162-214, 2017
2392017
Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders
B Bandelow, U Seidler-Brandler, A Becker, D Wedekind, E Rüther
The World Journal of Biological Psychiatry 8 (3), 175-187, 2007
2252007
What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
B Bandelow, DS Baldwin, OT Dolberg, HF Andersen, DJ Stein
Journal of Clinical Psychiatry 67 (9), 1428-1434, 2006
2242006
Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder
B Bandelow, A Charimo Torrente, D Wedekind, A Broocks, G Hajak, ...
European archives of psychiatry and clinical neuroscience 254 (6), 397-405, 2004
2242004
Neuropeptide S receptor gene—converging evidence for a role in panic disorder
K Domschke, A Reif, H Weber, J Richter, C Hohoff, P Ohrmann, ...
Molecular psychiatry 16 (9), 938-948, 2011
2032011
Panic and Agoraphobia Scale (PAS).
B Bandelow
Hogrefe & Huber Publishers, 1999
1941999
Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder
B Bandelow, C Späth, GÁ Tichauer, A Broocks, G Hajak, E Rüther
Comprehensive psychiatry 43 (4), 269-278, 2002
1882002
Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo-and …
B Bandelow, G Chouinard, J Bobes, A Ahokas, I Eggens, S Liu, ...
The The International Journal of Neuropsychopharmacology 13 (3), 305-320, 2010
1722010
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies
A Erhardt, L Czibere, D Roeske, S Lucae, PG Unschuld, S Ripke, ...
Molecular psychiatry 16 (6), 647-663, 2011
1672011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20